21/10/2023
Last week, we sat down with William Xiang (Willie) in his office at Xizhi District, Taiwan to talk about biotech, his career in financial services and biopharma, starting Nucleate Taiwan, and his favorite TV show.
He is the Co-Managing Director for Nucleate Taiwan and Head of Strategy and R&D Operations at XWPharma. He has had a diverse work experience in several roles and companies.
At XWPharma, Willie helped the company successfully fundraised three equity venture rounds totaling US$70 million. He has expanded XWPharmaβs global operations from Mainland China to the US, Taiwan, and Australia.
Prior to joining XWPharma, Willie worked at The Vanguard Group, the worldβs largest mutual fund company. Heβs responsible for data analytics and strategy as a Senior Analyst in the Business Channel Strategy Group focusing on Vanguardβs largest broker-dealer clients such as Merrill Lynch, Morgan Stanley, UBS, and Wells Fargo.
He holds an MBA from University of Chicago Booth School of Business, and received his BS in Psychology with a minor in Neuroscience from Haverford College.
Listen to full episode via this link
linktr.ee/sansel
To get in touch with Willie and Nucleate, check the show note.